Biogen (BIIB) Misses Q1 EPS by 76c, Announces CEO Transition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $240.98 -0.87%
EPS Growth %: -58.0%
Financial Fact:
Amortization of acquired intangible assets: 99.7M
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: -58.0%
Financial Fact:
Amortization of acquired intangible assets: 99.7M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $3.62, $0.76 worse than the analyst estimate of $4.38. Revenue for the quarter came in at $2.53 billion versus the consensus estimate of $2.5 billion.
- Announces CEO Transition
- Reaffirms FY Guidance
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Graco Q3 sales rise 8%, net earnings fall 12% on prior year gain
- SL Green Realty (SLG) Tops Q3 EPS by 226c
- Ardent Health names Gaurav Khanna as chief digital officer
Create E-mail Alert Related Categories
Corporate News, Earnings, Hot Corp. News, Hot Earnings, Hot Mgmt Changes, Management ChangesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
